Dimension Therapeutics' IPO

Dimension Therapeutics raised a round of funding on October 22, 2015. Investors include Public.

Dimension Therapeutics is focused on advancing its platform of gene therapy programs in rare diseases through clinical development, starting with lead programs in hemophilia, and building out a world-…

Articles about Dimension Therapeutics' IPO: